Barclays Starts NVO, SNY at Overweight, GSK, AZN at Equalweight, NVS at Underweight
Tweet Send to a Friend
In the Healthcare sector, an analyst at Barclays has initiated coverage on several of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
